Literature DB >> 20886247

Impact of tight control strategy on rheumatoid arthritis in Sarawak.

Cheng Lay Teh1, Jin Shyan Wong.   

Abstract

The aim of our study is to describe the impact of tight control strategy on the care of RA patients in Sarawak General Hospital. We performed a prospective study of all patients with a diagnosis of RA who received treatment at the Rheumatology Clinic in Sarawak General Hospital over a 1-year period. Systematic DAS-driven treatment adjustments aimed to achieve low disease activity (DAS 28-ESR <2.6) were carried out in the clinic over the 1-year period. Disease activity and treatment regimes of all 142 patients were collected for at baseline and 1 year later for statistical analysis. Our patients have a significantly lower DAS 28 with a mean of 2.99 ± 0.95 compared with baseline of 4.31 ± 1.34 (p < 0.000). More patients were in remission 1 year later compared to baseline (36.6% vs 11.3%). Tight control strategy has a positive impact on the care of RA patients in our centre. By optimising the care of RA through tight control strategy, RA can be better controlled in our centre.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20886247     DOI: 10.1007/s10067-010-1583-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.

Authors:  Tuulikki Sokka; Theodore Pincus
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Methotrexate is the leading DMARD in Finland.

Authors:  T Klaukka; K Kaarela
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

3.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.

Authors:  M M Ward; J F Fries
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

6.  Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Timo Möttönen; Pekka Hannonen; Markku Korpela; Martti Nissilä; Hannu Kautiainen; Jorma Ilonen; Leena Laasonen; Oili Kaipiainen-Seppänen; Per Franzen; Tapani Helve; Juhani Koski; Marianne Gripenberg-Gahmberg; Riitta Myllykangas-Luosujärvi; Marjatta Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  2002-04

7.  Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup.

Authors:  K W Drossaers-Bakker; A H Zwinderman; T P M Vliet Vlieland; D Van Zeben; K Vos; F C Breedveld; J M W Hazes
Journal:  Arthritis Rheum       Date:  2002-08

8.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

Authors:  Catriona Grigor; Hilary Capell; Anne Stirling; Alex D McMahon; Peter Lock; Ramsay Vallance; Wilma Kincaid; Duncan Porter
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

9.  QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Sergio Toloza; Heidi Mäkinen; Suzan M M Verstappen; Merete Lund Hetland; Antonio Naranjo; Eva Baecklund; Gertraud Herborn; Rolf Rau; Massimiliano Cazzato; Laure Gossec; Vlado Skakic; Feride Gogus; Stanislaw Sierakowski; Barry Bresnihan; Peter Taylor; Catherine McClinton; Theodore Pincus
Journal:  Ann Rheum Dis       Date:  2007-04-05       Impact factor: 19.103

10.  Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States.

Authors:  T Sokka; T Pincus
Journal:  Rheumatology (Oxford)       Date:  2008-08-07       Impact factor: 7.580

View more
  1 in total

1.  Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?

Authors:  Bee Eng Tan; Ai Lee Lim; Sow Lai Kan; Chong Hong Lim; Ying Fun Ng; Serene Li Ching Tng; Nur Syakirah Hassin; Losshenee Chandran; Norshahida Abdul Hamid; Yvonne Yin Leng Lee
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.